Who owns Milestone Pharmaceuticals Inc?
- Ticker: MIST
- CUSIP Number: 59935v107
Tip: Access positions for across all investors
Analyze quarterly positions in Milestone Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Milestone Pharmaceuticals stock
Who bought or sold Milestone Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 7.0M | $14M | 100% | Sep 2025 |
|
| Propel Bio Management | 4.1M | $8.3M | -20% | Dec 2025 |
|
| Rtw Investments | 2.5M | $5.1M | 0% | Dec 2025 |
|
| Marshall Wace | 1.7M | $3.3M | 290% | Dec 2025 |
|
| Simplify Asset Management | 1.5M | $3.0M | -47% | Dec 2025 |
|
| Susquehanna International | 1.2M | $2.5M | 129% | Dec 2025 |
|
| Jane Street | 1.2M | $2.5M | 189% | Dec 2025 |
|
| Pathstone Holdings | 1.0M | $2.1M | 2% | Dec 2025 |
|
| Lion Point Capital | 755k | $1.5M | 15% | Dec 2025 |
|
| Toronto-Dominion Bank | 750k | $1.5M | 0% | Sep 2025 |
|
| Boxer Capital Management | 667k | $1.3M | 0% | Dec 2025 |
|
| Two Sigma Investments | 667k | $1.3M | 100% | Sep 2025 |
|
| Stonepine Capital Management | 663k | $1.3M | 100% | Dec 2025 |
|
| Citadel Advisors | 592k | $1.2M | 1248% | Sep 2025 |
|
| UBS Group | 492k | $994k | 24% | Dec 2025 |
|
| Point72 Asset Management | 482k | $974k | 100% | Dec 2025 |
|
| Millennium Management | 402k | $803k | 100% | Sep 2025 |
|
| Aptus Capital Advisors | 263k | $532k | 25% | Dec 2025 |
|
| Guardian Wealth Advisors, Llc / Nc | 263k | $532k | 25% | Dec 2025 |
|
| Squarepoint Ops | 249k | $504k | 100% | Dec 2025 |
|
| GSA Capital Partners | 236k | $477k | 200% | Dec 2025 |
|
| Two Sigma Advisers | 234k | $468k | 100% | Sep 2025 |
|
| AMH Equity | 232k | $463k | 100% | Sep 2025 |
|
| Nomura Holdings | 225k | $455k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 222k | $448k | 100% | Dec 2025 |
|
| Group One Trading | 195k | $394k | 2678% | Dec 2025 |
|
| Acadian Asset Management | 176k | $353k | 100% | Dec 2025 |
|
| XTX Topco | 172k | $347k | -8% | Dec 2025 |
|
| Royal Bank of Canada | 143k | $287k | 303% | Sep 2025 |
|
| LPL Financial | 143k | $288k | 49% | Dec 2025 |
|
| Graham Capital Management | 134k | $270k | 100% | Dec 2025 |
|
| Valeo Financial Advisors | 131k | $264k | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 100k | $202k | 100% | Dec 2025 |
|
| Tru Independence Asset Management 2 | 100k | $202k | 100% | Dec 2025 |
|
| SG Americas Securities | 97k | $197k | 100% | Dec 2025 |
|
| Cascades Capital Asset Management | 78k | $157k | 0% | Dec 2025 |
|
| Geode Capital Management | 74k | $150k | 0% | Dec 2025 |
|
| Engineers Gate Manager | 59k | $119k | 100% | Dec 2025 |
|
| October Effect | 52k | $105k | 100% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 47k | $95k | 271% | Dec 2025 |
|
| Northern Trust | 39k | $79k | 0% | Dec 2025 |
|
| Colony | 36k | $73k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 35k | $70k | 100% | Dec 2025 |
|
| Scientech Research | 30k | $61k | 100% | Dec 2025 |
|
| Journey Strategic Wealth | 30k | $61k | 200% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 30k | $60k | 0% | Dec 2025 |
|
| Bay Rivers Group | 29k | $58k | 73% | Dec 2025 |
|
| Raymond James Financial | 27k | $54k | 0% | Dec 2025 |
|
| Safeguard Investment Advisory Group | 25k | $51k | 0% | Dec 2025 |
|
| Mariner Wealth Advisors | 25k | $51k | 0% | Dec 2025 |
|
| Creative Planning | 23k | $47k | 0% | Dec 2025 |
|
| Invesco | 22k | $44k | 100% | Dec 2025 |
|
| State Street Corporation | 22k | $44k | -2% | Dec 2025 |
|
| Cetera Investment Advisers | 21k | $42k | 100% | Dec 2025 |
|
| Stephenson & Company | 20k | $40k | 0% | Dec 2025 |
|
| Quantbot Technologies | 19k | $38k | 100% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 19k | $38k | 0% | Dec 2025 |
|
| Bayesian Capital Management | 17k | $35k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 16k | $32k | 45% | Dec 2025 |
|
| SJS Investment Consulting | 15k | $30k | 100% | Dec 2025 |
|
| Beta Wealth | 14k | $29k | 0% | Dec 2025 |
|
| Eaton Financial Holdings Company | 13k | $26k | 100% | Dec 2025 |
|
| Strategic Family Wealth Counselors | 13k | $26k | 100% | Dec 2025 |
|
| Bronte Capital Management Pty | 10k | $21k | 100% | Dec 2025 |
|
| Taylor Financial Group | 10k | $20k | 0% | Dec 2025 |
|
| Integral Investment Advisors | 10k | $20k | 100% | Dec 2025 |
|
| Ancora Advisors | 10k | $20k | 0% | Dec 2025 |
|
| Secure Asset Management | 10k | $20k | 0% | Dec 2025 |
|
| AQR Capital Management | 10k | $20k | 100% | Sep 2025 |
|
| Tower Research Capital | 9.0k | $18k | 100% | Dec 2025 |
|
| Us Bancorp | 3.2k | $6.5k | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 1.7k | $3.4k | 100% | Dec 2025 |
|
| SRS Capital Advisors | 1.6k | $3.2k | 48% | Dec 2025 |
|
| Rialto Wealth Management | 300.00 | $606.000000 | 100% | Dec 2025 |
|
| Key Capital Management | 212.00 | $428.006800 | 100% | Dec 2025 |
|
| SBI Securities | 6.00 | $12.000000 | 0% | Dec 2025 |
|
Who sold out of Milestone Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OrbiMed Advisors | Sep 2025 | 3.2M | $6.4M |
| Sphera Funds Management | Sep 2025 | 820k | $1.6M |
| Affinity Asset Advisors | Sep 2025 | 667k | $1.3M |
| Goldman Sachs Group | Sep 2025 | 357k | $713k |
| Hrt Financial | Sep 2025 | 139k | $277k |
| Simplex Trading | Sep 2025 | 67k | $133k |
| Sapient Capital | Sep 2025 | 12k | $25k |
| Sontag Advisory | Sep 2025 | 1.1k | $2.3k |